Paper38149643
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.
Wade R and 11 others. Health Technol Assess, 2023. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis. Papers, record 38149643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38149643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Ablation Techniques | Major topic |
| Humans | |
| Ethanol | |
| Prospective Studies | |
| Randomized Controlled Trials as Topic |
Source PubMed
References292
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28299619 | Double- and Triple-Positive Tumor Markers Predict Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh Class A. | J Gastrointest Surg | 2017 | https://conductscience.org/library/papers/28299619 | PubMed |
| 2 | 25287439 | Cryoablation provides superior local control of primary hepatocellular carcinomas of >2 cm compared with radiofrequency ablation and microwave coagulation therapy: an underestimated tool in the toolbox. | Ann Surg Oncol | 2015 | https://conductscience.org/library/papers/25287439 | PubMed |
| 3 | 33708637 | Laparoscopic Liver Resection versus Percutaneous Radiofrequency Ablation for Small Single Nodular Hepatocellular Carcinoma: Comparison of Treatment Outcomes. | Liver Cancer | 2021 | https://conductscience.org/library/papers/33708637 | PubMed |
| 4 | 28983565 | The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. | JAMA Oncol | 2017 | https://conductscience.org/library/papers/28983565 | PubMed |
| 5 | 16004810 | [Prophylaxis and clinical treatment for surgical margin recurrence of small primary hepatocellular carcinoma]. | Ai Zheng | 2005 | https://conductscience.org/library/papers/16004810 | PubMed |
| 6 | 24863168 | Quality of life after surgical resection compared with radiofrequency ablation for small hepatocellular carcinomas. | Br J Surg | 2014 | https://conductscience.org/library/papers/24863168 | PubMed |
| 7 | 16419155 | Percutaneous ethanol injection, radiofrequency and their combination in treatment of hepatocellular carcinoma. | World J Gastroenterol | 2005 | https://conductscience.org/library/papers/16419155 | PubMed |
| 8 | 35116757 | Transcatheter embolization of hepatocellular carcinoma with epirubicin-loaded DC beads in Chinese patients. | Transl Cancer Res | 2019 | https://conductscience.org/library/papers/35116757 | PubMed |
| 9 | 31774468 | Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial. | JAMA Oncol | 2020 | https://conductscience.org/library/papers/31774468 | PubMed |
| 10 | 31433531 | Factors related to the quality of life in liver cancer patients during treatment phase: A follow-up study. | Eur J Cancer Care (Engl) | 2019 | https://conductscience.org/library/papers/31433531 | PubMed |
| 11 | 18823439 | Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas. | J Gastroenterol Hepatol | 2009 | https://conductscience.org/library/papers/18823439 | PubMed |
| 12 | 26984844 | Comparison of laparoscopic hepatectomy, percutaneous radiofrequency ablation and open hepatectomy in the treatment of small hepatocellular carcinoma. | J Zhejiang Univ Sci B | 2016 | https://conductscience.org/library/papers/26984844 | PubMed |
| 13 | 22157201 | Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. | Radiology | 2012 | https://conductscience.org/library/papers/22157201 | PubMed |
| 14 | 30504537 | Surgical resection vs radiofrequency ablation in older adults with early stage hepatocellular carcinoma: Where do we stand? | Saudi J Gastroenterol | 2018 | https://conductscience.org/library/papers/30504537 | PubMed |
| 15 | 24750429 | Laparoscopic microwave ablation in patients with hepatocellular carcinoma: a prospective cohort study. | HPB (Oxford) | 2014 | https://conductscience.org/library/papers/24750429 | PubMed |
| 16 | 30449954 | Sensitivity of treatment recommendations to bias in network meta-analysis. | J R Stat Soc Ser A Stat Soc | 2018 | https://conductscience.org/library/papers/30449954 | PubMed |
| 17 | 26893018 | Modified radiofrequency ablation for the treatment of hepatocellular carcinoma. | Hepatol Res | 2016 | https://conductscience.org/library/papers/26893018 | PubMed |
| 18 | 26896371 | Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma. | Radiat Oncol | 2016 | https://conductscience.org/library/papers/26896371 | PubMed |
| 19 | 22095524 | Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study. | J Gastrointest Surg | 2012 | https://conductscience.org/library/papers/22095524 | PubMed |
| 20 | 33029483 | Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria. | Ann Surg Treat Res | 2020 | https://conductscience.org/library/papers/33029483 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794898 | Histotripsy Outcomes for Primary and Metastatic Hepatic Disease. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42794898 | PubMed |
| 42273140 | Pharmacokinetics and anti-tumor efficacy of transarterial chemoembolization using small-particle lenvatinib-loaded beads in a rabbit VX2 liver tumor model. | Quant Imaging Med Surg | 2026 | https://conductscience.org/library/papers/42273140 | PubMed |
| 42222382 | Constructing and validating a prognostic prediction nomogram model for hepatocellular carcinoma patients following high-intensity focused ultrasound treatment. | Front Oncol | 2026 | https://conductscience.org/library/papers/42222382 | PubMed |
| 41473256 | Protein Induced by Vitamin K Absence or Antagonist II in Primary Liver Cancer: Basic Research Insights and Clinical Applications. | J Clin Transl Hepatol | 2025 | https://conductscience.org/library/papers/41473256 | PubMed |
| 41010594 | Surgery Without Scalpel: Histotripsy as a Non-Invasive and Non-Thermal Modality for Liver Tumor Ablation. | J Clin Med | 2025 | https://conductscience.org/library/papers/41010594 | PubMed |
| 39851944 | Comparison of CT-Guided Microwave Ablation of Liver Malignancies with and Without Intra-Arterial Catheter Placement for Contrast Administration. | Curr Oncol | 2025 | https://conductscience.org/library/papers/39851944 | PubMed |
| 39041258 | LncRNA DERCNC in Hepatocellular Carcinoma with Cirrhosis Aggravates Tumor Proliferation by Targeting SOX9. | Curr Cancer Drug Targets | 2025 | https://conductscience.org/library/papers/39041258 | PubMed |
| 37902128 | The effectiveness of ablative and non-surgical therapies for early hepatocellular carcinoma: Systematic review and network meta-analysis of randomised controlled trials. | Cancer Med | 2023 | https://conductscience.org/library/papers/37902128 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38149643
GET https://conductscience.org/api/papers/v1/38149643/references?page=2